200 related articles for article (PubMed ID: 33081161)
1. Personalisation of Molecular Radiotherapy through Optimisation of Theragnostics.
Davis L; Smith AL; Aldridge MD; Foulkes J; Peet C; Wan S; Gains JE; Bomanji JB; Gaze MN
J Pers Med; 2020 Oct; 10(4):. PubMed ID: 33081161
[TBL] [Abstract][Full Text] [Related]
2. Clinical perspectives on dosimetry in molecular radiotherapy.
Davis L; Elmaraghi C; Buscombe JR; Gaze MN
Phys Med; 2023 Oct; 114():103154. PubMed ID: 37805342
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Medicine and Cancer Theragnostics: Basic Concepts.
Zoi V; Giannakopoulou M; Alexiou GA; Bouziotis P; Thalasselis S; Tzakos AG; Fotopoulos A; Papadopoulos AN; Kyritsis AP; Sioka C
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835806
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
[TBL] [Abstract][Full Text] [Related]
5. Current Status of Radiopharmaceutical Therapy.
St James S; Bednarz B; Benedict S; Buchsbaum JC; Dewaraja Y; Frey E; Hobbs R; Grudzinski J; Roncali E; Sgouros G; Capala J; Xiao Y
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):891-901. PubMed ID: 32805300
[TBL] [Abstract][Full Text] [Related]
6. ICRP Publication 140: Radiological Protection in Therapy with Radiopharmaceuticals.
Yonekura Y; Mattsson S; Flux G; Bolch WE; Dauer LT; Fisher DR; Lassmann M; Palm S; Hosono M; Doruff M; Divgi C; Zanzonico P
Ann ICRP; 2019 Sep; 48(1):5-95. PubMed ID: 31565950
[TBL] [Abstract][Full Text] [Related]
7. Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy.
DeNardo GL; Siantar CL; DeNardo SJ
Cancer Biother Radiopharm; 2002 Feb; 17(1):107-18. PubMed ID: 11915167
[TBL] [Abstract][Full Text] [Related]
8. Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools.
Ljungberg M; Sjögreen Gleisner K
Biomedicines; 2016 Nov; 4(4):. PubMed ID: 28536392
[TBL] [Abstract][Full Text] [Related]
9. Future trends for patient-specific dosimetry methodology in molecular radiotherapy.
Gustafsson J; Taprogge J
Phys Med; 2023 Nov; 115():103165. PubMed ID: 37880071
[TBL] [Abstract][Full Text] [Related]
10. Theragnostic radionuclides: a clinical perspective.
Koziorowski J; Ballinger J
Q J Nucl Med Mol Imaging; 2021 Dec; 65(4):306-314. PubMed ID: 34881851
[TBL] [Abstract][Full Text] [Related]
11. The impact of PET and SPECT on dosimetry for targeted radionuclide therapy.
Flux G; Bardies M; Monsieurs M; Savolainen S; Strands SE; Lassmann M;
Z Med Phys; 2006; 16(1):47-59. PubMed ID: 16696370
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of
Riveira-Martin M; Akhavanallaf A; Mansouri Z; Bianchetto Wolf N; Salimi Y; Ricoeur A; Mainta I; Garibotto V; López Medina A; Zaidi H
EJNMMI Res; 2023 Jul; 13(1):63. PubMed ID: 37395912
[TBL] [Abstract][Full Text] [Related]
13. Radiation Dosimetry of Theragnostic Pairs for Isotopes of Iodine in IAZA.
Jans HS; Stypinski D; Kumar P; Mercer JR; McQuarrie SA; McEwan AJB; Wiebe LI
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015281
[TBL] [Abstract][Full Text] [Related]
14. Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer.
Beauregard JM
Cancer Imaging; 2022 Dec; 22(1):67. PubMed ID: 36494731
[TBL] [Abstract][Full Text] [Related]
15. Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (
Wahl RL; Frey EC; Jacene HA; Kahl BS; Piantadosi S; Bianco JA; Hammes RJ; Jung M; Kasecamp W; He B; Sgouros G; Flinn IW; Swinnen LJ
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34204102
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.
Pauwels S; Barone R; Walrand S; Borson-Chazot F; Valkema R; Kvols LK; Krenning EP; Jamar F
J Nucl Med; 2005 Jan; 46 Suppl 1():92S-8S. PubMed ID: 15653657
[TBL] [Abstract][Full Text] [Related]
18. Metabolic imaging in non-small-cell lung cancer radiotherapy.
Geets X; Sterpin E; Wanet M; Di Perri D; Lee J
Cancer Radiother; 2014 Oct; 18(5-6):402-5. PubMed ID: 25179249
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II trials of
Denis-Bacelar AM; Chittenden SJ; Dearnaley DP; Divoli A; O'Sullivan JM; McCready VR; Johnson B; Du Y; Flux GD
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):620-629. PubMed ID: 27770145
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in
Plyku D; Hobbs RF; Huang K; Atkins F; Garcia C; Sgouros G; Van Nostrand D
J Nucl Med; 2017 Jul; 58(7):1146-1154. PubMed ID: 28104741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
